Radiology Doctors in Saint Augustine, FL Accepting Medicare

9 Radiology doctors found. Showing 1 - 9

Mandana Davani, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 Health Park Blvd, Attn: Radiology Department, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Janice L Vucinich, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 Health Park Blvd, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Miriam Niveen Mikhail, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 400 Health Park Blvd, Attn: Radiology Department, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Robert B Taliaferro, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 Health Park Blvd, Attn: Radiology Department, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Milton T. Mendenhall, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 Health Park Blvd, Attn: Radiology Department, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Dr. Arif Salah Kidwai, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 Health Park Blvd, Attn: Radiology Department, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Mrs. Ann Sweeney, RA Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 2202 S Cranbrook Ave, Saint Augustine, FL 32092 Phone: 440-787-8138

James Leroy Builteman, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 Health Park Blvd, Attn: Radiology Department, Saint Augustine, FL 32086 Phone: 904-819-4398    Fax: 904-819-4976

Kok L. Chong, MD Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 2720 Us Highway 1 S Ste C, Saint Augustine, FL 32086 Phone: 904-320-0680    Fax: 904-320-0800

News Archive

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded a $6.3 million contract by the National Institute of Mental Health (NIMH) to conduct preclinical safety studies of promising novel ligands that will be used for brain imaging research and clinical applications.

It's Saturday night for Senate test vote on health reform

The New York Times: "The Senate is expected to vote Saturday on whether to take up the legislation. The majority leader, Harry Reid, Democrat of Nevada, refused to say Thursday whether he had the 60 votes needed to clear that procedural hurdle."

Researchers have found a signal that could lead to earlier detection and treatment of ovarian cancer

The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.

Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA).

Read more Medical News

› Verified 2 days ago